Skip to main content
. 2004 Mar;72(3):1374–1382. doi: 10.1128/IAI.72.3.1374-1382.2004

FIG. 6.

FIG. 6.

Percent change in pre- and posttreatment antibody titers to each gingipain component in individual patients. Patients with undetectable pretreatment titers to rHA2 were assigned a titer of 1 to enable the calculation of percentage increase posttreatment.

HHS Vulnerability Disclosure